Preview

Russian Journal of Pediatric Hematology and Oncology

Advanced search
Fullscreen

For citations:


Kulyova S.A., Varfolomeeva S.R., Kirgizov K.I., Prosekina E.A., Romantsova O.M., Gorbunova T.V. A phase III, multicenter, open-label study of dinutuximab beta without/with chemotherapy at the investigator’s choice in patients under 18 years old with bone and soft tissue sarcomas with positive expression GD2 and disease progression during the first-line chemotherapy. Russian Journal of Pediatric Hematology and Oncology. 2024;11(2):12-20. (In Russ.) https://doi.org/10.21682/2311-1267-2024-11-2-12-20



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2311-1267 (Print)
ISSN 2413-5496 (Online)
X